General Pharmaceutical Council determination — substantive hearing
GPhC suspended Michael James McGinty for six months in July 2024
The committee recognised insight and remediation but found further work was needed to address risk. It ordered suspension with review following a drink-driving conviction and attendance at work while unfit.
MedicWatch editorial · Published 17 July 2024 · Updated 22 September 2026
Suspension (suspended from practice) — 6 months
Data last checked: 22 September 2026Report a correction
What does “suspended from practice” mean?
The regulator imposed a fixed-term suspension in this decision. Its start date, appeal provisions and any later review affect whether it is currently in force. Check the official register for the practitioner's current status.
Concerning Michael James McGinty, pharmacist (General Pharmaceutical Council 2036097).
Decision date: 17 July 2024 · Hearing started 15 July 2024 and ended 17 July 2024
This sanction period has elapsed.
In plain English
The GPhC committee suspended Michael James McGinty for six months in July 2024 following a drink-driving conviction and attendance at work in an unfit state. It found impaired fitness to practise, recognising insight and significant remediation but identifying further work needed to address risk. No actual patient harm was found. The order required review; the public decision redacts private medical details.
Charges
The allegations concerned a September 2021 drink-driving conviction, attending work as the sole pharmacist in an unfit state in March 2023, and a medical condition whose details are redacted in the public determination. The registrant admitted the particulars.
Findings
The committee found misconduct and impaired fitness to practise. It recognised insight and significant remediation but concluded further work was needed and a risk of repetition remained. It found no actual patient harm, while identifying serious potential risk and disruption of pharmacy services. It imposed six months' suspension with review and immediate interim suspension covering the appeal period. Private medical details are redacted.
Mitigating and aggravating factors
Mitigating factors
a. The Registrant had made admissions and had apologised for his conduct. b. The Registrant had shown insight, remorse and regret. c. He had a long unblemished career for a period of over 35 years. d. The Registrant had suffered from personal problems REDACTED e. He had fully co-operated with his regulator REDACTED f. There had been no personal gain to the Registrant by his conduct. g. REDACTED h. REDACTED
Aggravating factors
a. There had been two serious incidents, both alcohol related, over a period of 3 years which had placed patients and members of the public at risk of serious harm. b. The Registrant had made two separate decisions - to drive after consuming excessive alcohol and to attend work while in an unfit state. This demonstrated a pattern of behaviour albeit those incidents were related to the Registrant’s health. c. The Pharmacy had to be closed on 28 March 2023 for at least an hour which meant that patients were unable to access the care they may have needed and service was disrupted. d. REDACTED
Source
All facts on this page are drawn from the publicly published General Pharmaceutical Council determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.